What The NIH Budget Cuts Mean For Your HEALTH

Most people have no idea how much time, money, and testing it takes to bring a new drug to market. But with the new administration slashing federal health staff and cutting NIH funding, the future of drug development is on the line.

In this video, Dr. Evan Nadler breaks down:

● What it actually costs to develop a drug from idea to approval
● Why the GLP-1 obesity meds you’ve heard about took over a decade to reach you
● How FDA trials work (and what gets skipped when funding disappears)
● The real risk behind anti–big pharma rhetoric: less innovation, fewer breakthroughs

Whether you’re curious about how your meds get made or concerned about public health policy, this episode lays it out clearly, calmly, and with evidence.

Watch the full episode below.